Top Story

Treatment options vary in patients with bisphosphonate-related femur fractures

Treatment options vary in patients with bisphosphonate-related femur fractures
January 16, 2019

FDA advisory committee recommends approval of romosozumab for osteoporosis

January 15, 2019
The Bone, Reproductive and Urologic Drugs Advisory Committee of the FDA voted 18-1 Wednesday in favor of recommending approval of a biologics license application for the…

BLOG: Modalities used to diagnose osteoporosis

December 20, 2018
This installment of osteoporosis primer for PAs will focus on the modalities used to diagnosis osteoporosis. To reiterate a diagnosis of osteoporosis could be made in an…

Pfenex submits new drug application for follow-on osteoporosis drug

December 11, 2018
Pfenex this week submitted a new drug application to the FDA seeking approval for PF708, a follow-on biosimilar referencing teriparatide for the treatment of…
More Headlines »
Feature Article

Mediolateral Subchondral Tibial Bone Mineral Density Difference Does Not Predict Osteoarthritis Progression

Orthopedics, April/May 2014, Volume 37 Issue 4
Data on the relationship between osteoporosis and osteoarthritis are conflicting. Most studies report “snapshot”…
More »

Goal-directed Therapy in Osteoporosis: Reaching a Consensus

This activity is supported by an educational grant from Radius Health, Inc.

Osteoporosis, a disorder characterized by compromised bone strength that increases the risk of fragility, leads to 1.5…
More »
Meeting News Coverage

VIDEO: Long-term oral bisphosphonate use mildly increases risk for osteonecrosis of the jaw

September 20, 2016
More »